References:
1- Ashurst, John, and Megan Wasson. ”Methemoglobinemia: a systematic review of the pathophysiology, detection, and treatment.” Delaware medical journal 83.7 (2011): 203-208.‏
2- Alanazi, Menyfah Q. ”Drugs may be induced methemoglobinemia.” J Hematol Thrombo Dis 5.3 (2017): 1-5.‏
3- Kielhofner, Marcia A. ”Trimethoprim-sulfamethoxazole: pharmacokinetics, clinical uses, and adverse reactions.” Texas Heart Institute Journal 17.2 (1990): 86.‏
4- Skold, Anna, Dominique L. Cosco, and Robin Klein. ”Methemoglobinemia: pathogenesis, diagnosis, and management.” South Med J 104.11 (2011): 757-761.‏
5- Rino, Pedro Bonifacio, et al. ”Ascorbic acid for the treatment of methemoglobinemia: the experience of a large tertiary care pediatric hospital.” American journal of therapeutics 21.4 (2014): 240-243.‏
6- Lopez, A., et al. ”Methaemoglobinaemia secondary to treatment with trimethoprim and sulphamethoxazole associated with inhaled nitric oxide.” Acta Paediatrica (Oslo, Norway: 1992) 88.8 (1999): 915-916.‏
7- Jakobson, B., and A. Nilsson. ”Methemoglobinemia associated with a prilocaine‐lidocaine cream and trimetoprim‐sulphamethoxazole. A case report.” Acta anaesthesiologica scandinavica 29.4 (1985): 453-455.‏
8- Carroll, Timothy G., and Megan G. Carroll. ”Methemoglobinemia in a pediatric oncology patient receiving sulfamethoxazole/trimethoprim prophylaxis.” The American journal of case reports 17 (2016): 499.‏
9- Radhakrishnan, Nita, and Ruchi Rai. ”Cotrimoxazole-induced Methemoglobinemia.” Indian pediatrics 54.9 (2017): 786-787.‏